![Alexander Mayweg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexander Mayweg
Chief Executive Officer at
Matterhorn Biosciences AG
Profile
Currently, Alexander Mayweg is Chairman-Management Board at Matterhorn Biosciences AG, Chairman at T-Knife GmbH, Cimeio Therapeutics AG, and Vertical Bio AG, Director at Enterprise Therapeutics Ltd. since 2018, Monte Rosa Therapeutics AG, and Bright Peak Therapeutics AG, Managing Director at Versant Ventures (Switzerland) GmbH since 2020, Director at Bright Peak Therapeutics, Inc. since 2017, President, Treasurer & Director at Revelio Therapeutics, Inc., and Chief Scientific Officer at Ridgeline Therapeutics and Ridgeline Discovery GmbH since 2017.
Formerly, Dr. Mayweg was Director at Monte Rosa Therapeutics, Inc. from 2018 to 2024, Director at Black Diamond Therapeutics, Inc. from 2017 to 2024, and Vice President & Global Head-Medicinal Chemistry at Roche Holding AG and F.
Hoffmann-La Roche Ltd. from 2013 to 2016.
Education includes a doctorate from the University of Oxford conferred in 2001 and an undergraduate degree from Imperial College London conferred in 1998.
Alexander Mayweg active positions
| Companies | Position | Start |
|---|---|---|
Versant Ventures (Switzerland) GmbH
 Versant Ventures (Switzerland) GmbH Investment ManagersFinance Acts as an alternative investment manager | Private Equity Investor | 01/07/2016 |
Monte Rosa Therapeutics AG
 Monte Rosa Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes cancer drugs that modulates protein degradation pathways | Director/Board Member | - |
Enterprise Therapeutics Ltd.
 Enterprise Therapeutics Ltd. BiotechnologyHealth Technology Develops novel therapies to patients suffering with respiratory diseases | Director/Board Member | 06/04/2018 |
Ridgeline Therapeutics | Chief Tech/Sci/R&D Officer | 01/04/2017 |
T-Knife GmbH
 T-Knife GmbH BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops novel therapeutics to fight cancer | Chairman | - |
Bright Peak Therapeutics AG
 Bright Peak Therapeutics AG BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Director/Board Member | - |
Bright Peak Therapeutics, Inc.
 Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for the treatment of cancer and autoimmune diseases | Director/Board Member | 01/12/2017 |
Cimeio Therapeutics AG
 Cimeio Therapeutics AG BiotechnologyHealth Technology Operates as a biotechnology company developing shielded-cell & immunotherapy pairs, which protect genetically modified cells from targeted therapies | Chairman | - |
Launchpad Therapeutics, Inc.
 Launchpad Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutics | President | - |
| ░░░░░░░░ ░░░ ░░ | ░░░░░░░░ | - |
Former positions of Alexander Mayweg
| Companies | Position | End |
|---|---|---|
| ░░░░░ ░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Alexander Mayweg
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
86
1st degree connections
17
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 17 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enterprise Therapeutics Ltd.
Enterprise Therapeutics Ltd. BiotechnologyHealth Technology Develops novel therapies to patients suffering with respiratory diseases | Health Technology |
Versant Ventures (Switzerland) GmbH
Versant Ventures (Switzerland) GmbH Investment ManagersFinance Acts as an alternative investment manager | Finance |
Black Diamond Therapeutics, Inc.
 Black Diamond Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops precision medicines for cancer | Health Technology |
Monte Rosa Therapeutics AG
Monte Rosa Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes cancer drugs that modulates protein degradation pathways | Health Technology |
Bright Peak Therapeutics AG
Bright Peak Therapeutics AG BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Health Technology |
Ridgeline Therapeutics | |
T-Knife GmbH
T-Knife GmbH BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops novel therapeutics to fight cancer | Health Technology |
Matterhorn Biosciences AG
 Matterhorn Biosciences AG BiotechnologyHealth Technology Engages in research and development of cell receptor therapies | Health Technology |
Monte Rosa Therapeutics, Inc.
 Monte Rosa Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecular glue degrader medicines for oncology, autoimmune and inflammatory diseases | Health Technology |
Bright Peak Therapeutics, Inc.
Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for the treatment of cancer and autoimmune diseases | Health Technology |
Cimeio Therapeutics AG
Cimeio Therapeutics AG BiotechnologyHealth Technology Operates as a biotechnology company developing shielded-cell & immunotherapy pairs, which protect genetically modified cells from targeted therapies | Health Technology |
Launchpad Therapeutics, Inc.
Launchpad Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutics | Commercial Services |
Vertical Bio AG
 Vertical Bio AG BiotechnologyHealth Technology Develops novel cancer therapies | Health Technology |
- Stock Market
- Insiders
- Alexander Mayweg
